Jan Skvarka

Companies

• Monte Rosa TherapeuticsBoard member Mar 24, 2023 to now¹
• Zentalis Pharmaceuticals, Inc.Board member Sep 12, 2022 to now²
• Trillium Therapeutics Inc.Board member Jan 4, 2021 to Nov 19, 2021³
• Trillium Therapeutics Inc.Chief executive officer Jan 4, 2021 to Nov 19, 2021³
• Trillium Therapeutics Inc.President Jan 4, 2021 to Nov 19, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ZPZentalis Pharmaceuticals, Inc. ZNTL264,254 shares⁴$590.6K at $2.23Jun 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 57,100 shares of Zentalis Pharmaceuticals, Inc.⁴
• Jun 17, 2025Granted 57,603 shares of Zentalis Pharmaceuticals, Inc.⁵
• Jan 31, 2025Bought 60,000 shares at $1.72 of Zentalis Pharmaceuticals, Inc.⁶
• Jun 21, 2024Granted 41,581 shares of Zentalis Pharmaceuticals, Inc.⁷
• Sep 11, 2023Sold 5,000 shares at $25.05 of Zentalis Pharmaceuticals, Inc.⁸
• Jun 16, 2023Granted 16,364 shares of Zentalis Pharmaceuticals, Inc.⁹
• Sep 9, 2022Granted 36,606 shares of Zentalis Pharmaceuticals, Inc.¹⁰